• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Primary melanoma regression may not be associated with reduced metastasis

byAngela WangandAdam Whittington
June 12, 2014
in Chronic Disease, Dermatology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Regression of primary melanomas greater than 0.75mm was not significantly correlated with changes in sentinel node (SN) status. 

2. Increased melanoma regression was associated with axial location and lesser Breslow thickness. 

Evidence Rating Level: 2 (Good)            

Study Rundown: Primary melanoma regression, likely due to inflammatory immune response, presents with reduced number of neoplastic cells and increased fibrosis, neovascularization, and inflammatory infiltrate.  Previous studies on its association with tumor metastasis have resulted in various conclusions.  Therefore, this study sought to determine whether primary melanoma regression in lesions greater than 0.75mm was associated with changes in SN status, and thus tumor metastasis.  The authors concluded that the presence or absence of tumor regression was not significantly associated with SN status and metastasis.  However, axial (head, neck, and trunk) location of the primary melanoma and lesion thickness of 1.00mm or less was statistically associated with regression.  Strengths of this study included its discussion of lesion thickness and previously reported associations with SN metastasis.  Future studies may include larger and more diverse patient populations, as well as primary melanomas smaller than 0.75mm.

Click to read the study in JAMA Dermatology

Relevant Reading: Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients

RELATED REPORTS

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

Ipilimumab/Nivolumab versus Nivolumab in Melanoma Brain Metastases

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

In-Depth [retrospective cohort]: This study assessed 201 melanomas in 201 patients at the Instituto Valenciano de Oncologia between January 1, 2003 and December 31, 2010.  Regressed lesions of greater than 0.75mm were categorized as either early or late regression, based on changes in melanoma cells and extent of fibrosis.  Primary melanomas were also characterized by binary variables such as age, sex, tumor location, ulceration, tumor infiltrating lymphocytes, Breslow thickness, mitotic index, extension of regression, and clinicopathic type, and analyzed using the χ2 test.  Results indicated no statistically significant relationship between melanoma regression and SN biopsy metastasis (P = 0.17).  However, Breslow thickness, mitosis, and clinicopathologic type was correlated with SN status (P = <0.001, 0.008, and <0.001 respectively).  Lastly, axial location of primary melanoma was found to be associated with regression (P = <0.001).

Image: PD 

More from this author: Video-based behavioral intervention benefits clinical skin examinations, Biofilm-producing staphylococci occlude eccrine sweat ducts in atopic dermatitis, Initial primary invasive or in situ melanoma increases risk of subsequent invasive melanoma, Various factors impact quality of life in patients with chronic pruritus, New Mohs sterilization guidelines may not affect infection rates 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: melanoma
Previous Post

Brodalumab effective in treating active psoriatic arthritis

Next Post

UK fails to reduce deaths of young people

RelatedReports

Significant reduction in prostate screening rates after revised guidelines
Chronic Disease

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

April 28, 2025
“No Evidence of Disease Activity” may be useful goal in multiple sclerosis
Chronic Disease

Ipilimumab/Nivolumab versus Nivolumab in Melanoma Brain Metastases

February 24, 2025
Increased risk of subsequent melanoma after first melanoma diagnosis
Dermatology

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

December 12, 2024
Medicare beneficiaries have a lower rate of delayed melanoma surgeries
Chronic Disease

Adjuvant dabrafenib and trametinib improve survival in stage III melanoma

November 25, 2024
Next Post
Successful regional implementation of pediatric chest pain algorithm

UK fails to reduce deaths of young people

Preoperative MRI may not benefit breast cancer patients

Mortality risk higher in pediatric trauma patients with chronic conditions

Surgeon-level decisions may impact needle biopsy use in breast cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early acetaminophen use reduces mortality risk in patients with sepsis-associated encephalopathy
  • Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
  • 2 Minute Medicine Rewind June 30, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.